ACOXL Inhibitors
ACOXL Inhibitors mainly centers around molecules that influence fatty acid oxidation, given that ACOXL is believed to be involved in this metabolic pathway. Most of the enlisted inhibitors, such as Thioridazine, Miconazole, and Perhexiline, directly target various steps of fatty acid oxidation, which could impact the function of ACOXL. Thioridazine, for instance, impedes peroxisomal fatty acid oxidation, potentially leading to a decreased ACOXL activity. Miconazole can also influence peroxisomal beta-oxidation, suggesting a consequential effect on ACOXL's function.
Further, some inhibitors, like Etomoxir and 2-Bromopalmitate, are more generic in their action, obstructing multiple enzymes involved in fatty acid oxidation. In such cases, it is inferred that ACOXL's function is in alignment with fatty acid oxidation, then its activity can be affected. Omeprazole, albeit a proton pump inhibitor, is included given its potential indirect influence on peroxisomal functionalities. The broader spectrum inhibitors, like Genistein and C75, have roles in influencing fatty acid oxidation and synthesis, respectively, but their impact on ACOXL would be contingent on the metabolic equilibrium of the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Thioridazine Hydrochloride | 130-61-0 | sc-201149A sc-201149 sc-201149B sc-201149C sc-201149D | 5 mg 1 g 5 g 25 g 100 g | $20.00 $49.00 $104.00 $416.00 $1248.00 | ||
By inhibiting peroxisomal fatty acid oxidation, Thioridazine can indirectly reduce ACOXL activity, given that ACOXL might be involved in the same pathway. | ||||||
Miconazole | 22916-47-8 | sc-204806 sc-204806A | 1 g 5 g | $66.00 $160.00 | 2 | |
Miconazole can affect peroxisomal beta-oxidation; by impeding this process, it might decrease the substrate availability or process efficiency for ACOXL. | ||||||
rac Perhexiline Maleate | 6724-53-4 | sc-460183 | 10 mg | $188.00 | ||
By inhibiting both mitochondrial and peroxisomal fatty acid oxidation, Perhexiline might limit the substrates for ACOXL, thereby indirectly reducing its activity. | ||||||
R-(+)-Etomoxir | 124083-20-1 | sc-208201A sc-208201 | 2 mg 5 mg | $245.00 $430.00 | ||
Etomoxir inhibits fatty acid oxidation; thus, it can potentially limit the fatty acid substrates that ACOXL would oxidize. | ||||||
2-Bromohexadecanoic acid | 18263-25-7 | sc-251714 sc-251714A | 10 g 50 g | $53.00 $201.00 | 4 | |
This brominated fatty acid inhibits enzymes in fatty acid oxidation. By impeding this general pathway, it can decrease the substrate availability for ACOXL. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Though primarily a proton pump inhibitor, Omeprazole might affect peroxisomal functions, potentially creating an environment less conducive for ACOXL activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein's role in inhibiting fatty acid oxidation can limit the pool of fatty acids that ACOXL can act upon. | ||||||
C75 (racemic) | 191282-48-1 | sc-202511 sc-202511A sc-202511B | 1 mg 5 mg 10 mg | $72.00 $206.00 $290.00 | 9 | |
As a fatty acid synthase inhibitor, C75 can affect overall fatty acid metabolism, indirectly reducing the substrates available for ACOXL to oxidize. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $38.00 $79.00 $188.00 $520.00 $1248.00 $5930.00 | 8 | |
By affecting mitochondrial functions, Niclosamide can indirectly impede fatty acid oxidation processes involving ACOXL. | ||||||
Nitazoxanide | 55981-09-4 | sc-212397 | 10 mg | $124.00 | 1 | |
Although primarily an antiprotozoal, Nitazoxanide can influence cellular metabolism pathways, potentially creating metabolic shifts that affect ACOXL's role in fatty acid oxidation. | ||||||